Journal of the National Comprehensive Cancer Network · 2024 · 47 citations · 61 references
MedicineOncologyRadiation OncologyOncologic SurgeryPediatric OncologySurgical OncologyPediatric Oncologic SurgeryPediatric Surgical OncologyClinical Practice Guidelines ImplementationMultidisciplinary CollaborationNeuroblastoma RadiotherapyNeuroblastoma SurgeryPediatric Neuroblastoma ImagingPreferred Risk Classification
Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.
61
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text
Medicine, Immunology, Oncology +14
Identification of ALK as a major familial neuroblastoma predisposition gene
Yaël P. Mossé, Marci Laudenslager, Luca Longo et al. · Nature · 2008 · 1.4K citations
The International Neuroblastoma Pathology Classification (the Shimada system)
Hiroyuki Shimada, Inge M. Ambros, Louis P. Dehner et al. · Cancer · 1999 · 1K citations